Benefits
Urinary Calcium Modulation
Phyllanthus niruri has been studied for its ability to reduce elevated urinary calcium excretion in calcium-stone-forming patients. By normalizing hypercalciuria, the herb may help maintain a less stone-promoting urinary environment when combined with adequate hydration.
Kidney Stone Support Tradition
Used for centuries in South American traditional medicine for 'stone breaking,' Phyllanthus niruri remains a widely recommended botanical for urolithiasis support. Modern data suggests it may help reduce stone-promoting factors though it does not directly dissolve existing stones.
Hepatoprotective Activity
Preclinical and small clinical studies have explored the herb's ability to protect liver cells from chemical and inflammatory stress. Constituents like phyllanthin and geraniin show antioxidant and anti-inflammatory activity relevant to general liver-support positioning.
Antioxidant Support
The polyphenol and ellagitannin fraction of Phyllanthus niruri exhibits substantial free-radical scavenging activity in vitro. This contributes to its broader use as a general 'cleansing' tonic in traditional and modern integrative practice.
Mechanism of action
Crystallization Inhibition
Aqueous extracts of Phyllanthus niruri interfere with calcium oxalate crystal nucleation and aggregation in laboratory models. This may help reduce the formation of new urinary crystals — a mechanism underlying its traditional 'stone breaker' use.
Urinary Calcium Normalization
Clinical data suggest the herb reduces elevated urinary calcium excretion in hypercalciuric patients. The mechanism is not fully defined but may involve modulation of renal calcium handling or intestinal absorption.
Antioxidant and Anti-Inflammatory Activity
Phyllanthin, hypophyllanthin, and ellagitannins scavenge reactive oxygen species and suppress inflammatory cytokine production in cell models. This dual antioxidant-anti-inflammatory profile supports the herb's hepatoprotective positioning.
Hepatic Enzyme Modulation
Animal studies have shown Phyllanthus niruri can normalize elevated liver enzymes (ALT, AST) in chemically-induced liver injury models. The herb's polyphenol fraction appears to support hepatocyte membrane integrity and detoxification capacity.
Clinical trials
Clinical study of Phyllanthus niruri (450 mg three times daily) over an extended treatment period in 56 calcium-stone-forming patients, including patients with hypercalciuria. Urinary biochemistry assessed before and during treatment. (Nishiura et al, Urol Res)
56 calcium-stone-forming patients, including hypercalciuric subgroup.
Phyllanthus niruri induced a significant reduction in mean urinary calcium in hypercalciuric patients without significant adverse effects. The result supports the herb's traditional positioning for urolithiasis support and provides modest contemporary clinical evidence for use as adjunctive stone-prevention therapy alongside hydration and standard care.
Comprehensive review of Phyllanthus niruri phytochemistry and pharmacology, including hepatoprotective, antiviral, antioxidant, and antilithic activity from preclinical and clinical studies. (Kaur et al, Phytother Res)
Narrative review of preclinical and human literature.
The review synthesizes evidence for hepatoprotective and antilithic activity, with stronger support for the urolithiasis indication than for antiviral hepatitis claims. Authors note Cochrane analyses of hepatitis B trials have been equivocal, supporting cautious framing of liver-disease claims while affirming the herb's traditional and pharmacologic profile.